about
Role of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseAntibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatmentRisk factors for acquisition of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae in North-Indian hospitalsCurrent acetylcholinesterase-inhibitors: a neuroinformatics perspective.Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach.Compounds isolated from Ageratum houstonianum inhibit the activity of matrix metalloproteinases (MMP-2 and MMP-9): An oncoinformatics study.Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders.Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: advancement in Alzheimer's disease- diabetes type 2 linkage via an enzoinformatics study.Prevalence of CTX-M resistance marker and integrons among Escherichia coli and Klebsiella pneumoniae isolates of clinical origin.An enzoinformatics study targeting polo-like kinases-1 enzyme: Comparative assessment of anticancer potential of compounds isolated from leaves of Ageratum houstonianumPrediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study.A neuroinformatics study describing molecular interaction of Cisplatin with acetylcholinesterase: a plausible cause for anticancer drug induced neurotoxicity.A neuroinformatics study to compare inhibition efficiency of three natural ligands (Fawcettimine, Cernuine and Lycodine) against human brain acetylcholinesterase.An enzoinformatics study for prediction of efficacies of three novel penem antibiotics against New Delhi metallo-β-lactamase-1 bacterial enzymeADNCD: a compendious database on anti-diabetic natural compounds focusing on mechanism of actionAn oncoinformatics study to predict the inhibitory potential of recent FDA-approved anti-cancer drugs against human Polo-like kinase 1 enzyme: a step towards dual-target cancer medication
P50
Q28083039-4988FAEB-02AE-4A84-98BC-6DA6EFF5255EQ34456773-E3EBD338-9841-4E34-9BAB-70B2EC91B9C7Q34800300-8225FB62-2FC5-4347-B7D4-079C1484C730Q38140959-00DAE508-591C-4689-BF6D-5A7CE46178F1Q38140962-C71B79A3-C39E-4A07-B43B-D9338F16E000Q38557167-EDA853F0-5F7C-4208-8AC0-0A14D232735DQ38906901-9839E740-E92A-485B-8041-66F22F994678Q39097245-FF06C7B6-5903-477C-B71A-8390481CF4EBQ39346058-294B8D7F-2904-442F-86F4-126DDBF2BD55Q39903359-5B9F45E4-6245-49F1-A265-C767942F3B9DQ40376895-68A2D969-77D3-40F0-AB5E-10FCAA4A869BQ46175618-0B7D7C21-D323-4BB9-8236-1F20D0D49C2FQ46248516-875BE272-2B9F-467C-AC99-F3413540F80CQ48365293-A3CD537C-8F09-4521-813F-2E9E4FDD638AQ85283013-EEA5C1A4-1F57-46E3-92FE-E41E763F5AF1Q90931522-D9FBD05F-D6DA-4B14-9867-2F267EC06408Q91875558-F2B4DB02-312D-4AD9-8530-CE3A6DBB39C4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Syed Mohd Danish Rizvi
@ast
Syed Mohd Danish Rizvi
@en
Syed Mohd Danish Rizvi
@es
Syed Mohd Danish Rizvi
@nl
type
label
Syed Mohd Danish Rizvi
@ast
Syed Mohd Danish Rizvi
@en
Syed Mohd Danish Rizvi
@es
Syed Mohd Danish Rizvi
@nl
prefLabel
Syed Mohd Danish Rizvi
@ast
Syed Mohd Danish Rizvi
@en
Syed Mohd Danish Rizvi
@es
Syed Mohd Danish Rizvi
@nl
P106
P1153
55905130400
P31
P496
0000-0002-3106-4707